M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma
Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We co...
Saved in:
Published in | Cancer science Vol. 114; no. 12; pp. 4521 - 4534 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.12.2023
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1‐like and M2‐like TAM distribution and EMT by E‐cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC‐1) and a human monocyte cell line (THP‐1) were used for in vitro experiments. M2‐like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E‐cadherin‐positive and 44 (19.9%) were vimentin‐positive. M2‐like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF‐β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF‐β1 secretion from TAMs was confirmed by ELISA. TAM‐co‐cultured H226 and EBC‐1 cells exhibited EMT (decreased E‐cadherin, increased vimentin). Regarding EMT‐activating transcriptional factors, phosphorylated Smad3 and ZEB‐family proteins were higher in TAM‐co‐cultured LUSC cells than in parental cells. TAM‐co‐cultured H226 and EBC‐1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC.
TAM‐co‐cultured LUSC cells exhibited EMT through the TGF‐beta/Smad/ZEB pathway. TAM‐co‐cultured LUSC cells demonstrated enhanced migration and invasion capabilities and increased tumor cell proliferation. |
---|---|
AbstractList | Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1-like and M2-like TAM distribution and EMT by E-cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC-1) and a human monocyte cell line (THP-1) were used for in vitro experiments. M2-like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E-cadherin-positive and 44 (19.9%) were vimentin-positive. M2-like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF-β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF-β1 secretion from TAMs was confirmed by ELISA. TAM-co-cultured H226 and EBC-1 cells exhibited EMT (decreased E-cadherin, increased vimentin). Regarding EMT-activating transcriptional factors, phosphorylated Smad3 and ZEB-family proteins were higher in TAM-co-cultured LUSC cells than in parental cells. TAM-co-cultured H226 and EBC-1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC. Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1‐like and M2‐like TAM distribution and EMT by E‐cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC‐1) and a human monocyte cell line (THP‐1) were used for in vitro experiments. M2‐like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E‐cadherin‐positive and 44 (19.9%) were vimentin‐positive. M2‐like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF‐β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF‐β1 secretion from TAMs was confirmed by ELISA. TAM‐co‐cultured H226 and EBC‐1 cells exhibited EMT (decreased E‐cadherin, increased vimentin). Regarding EMT‐activating transcriptional factors, phosphorylated Smad3 and ZEB‐family proteins were higher in TAM‐co‐cultured LUSC cells than in parental cells. TAM‐co‐cultured H226 and EBC‐1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC. TAM‐co‐cultured LUSC cells exhibited EMT through the TGF‐beta/Smad/ZEB pathway. TAM‐co‐cultured LUSC cells demonstrated enhanced migration and invasion capabilities and increased tumor cell proliferation. Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1-like and M2-like TAM distribution and EMT by E-cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC-1) and a human monocyte cell line (THP-1) were used for in vitro experiments. M2-like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E-cadherin-positive and 44 (19.9%) were vimentin-positive. M2-like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF-β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF-β1 secretion from TAMs was confirmed by ELISA. TAM-co-cultured H226 and EBC-1 cells exhibited EMT (decreased E-cadherin, increased vimentin). Regarding EMT-activating transcriptional factors, phosphorylated Smad3 and ZEB-family proteins were higher in TAM-co-cultured LUSC cells than in parental cells. TAM-co-cultured H226 and EBC-1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC.Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed to clarify the significance of TAMs in relation to EMT in LUSC. We collected 221 LUSC specimens from patients who had undergone surgery. Immunohistochemistry was performed to evaluate M1-like and M2-like TAM distribution and EMT by E-cadherin and vimentin staining. Human LUSC cell lines (H226 and EBC-1) and a human monocyte cell line (THP-1) were used for in vitro experiments. M2-like polarization of TAMs and EMT marker expression in LUSC cells were evaluated by western blotting. The biological behavior of LUSC cells was evaluated by migration, invasion, and cell proliferation assays. Immunohistochemical analysis showed that 166 (75.1%) tumors were E-cadherin-positive and 44 (19.9%) were vimentin-positive. M2-like TAM density in the tumor stroma was significantly associated with vimentin positivity and worse overall survival. Western blotting demonstrated higher levels of CD163, CD206, vascular endothelial growth factor, and transforming growth factor beta 1 (TGF-β1) in TAMs versus unstimulated macrophages. Furthermore, increased TGF-β1 secretion from TAMs was confirmed by ELISA. TAM-co-cultured H226 and EBC-1 cells exhibited EMT (decreased E-cadherin, increased vimentin). Regarding EMT-activating transcriptional factors, phosphorylated Smad3 and ZEB-family proteins were higher in TAM-co-cultured LUSC cells than in parental cells. TAM-co-cultured H226 and EBC-1 cells demonstrated enhanced migration and invasion capabilities and improved proliferation. Overall, the present study suggests that TAMs can induce EMT with increased metastatic potential and tumor cell proliferation in LUSC. |
Author | Sumitomo, Ryota Yutaka, Yojiro Hamaji, Masatsugu Huang, Cheng‐Long Haga, Hironori Toyazaki, Toshiya Chiba, Naohisa Yoshizawa, Akihiko Miyamoto, Hideaki Shimazu, Yumeta Nakajima, Daisuke Nishikawa, Shigeto Tanaka, Satona Sato, Atsuyasu Ohsumi, Akihiro Yamada, Yoshito Menju, Toshi Date, Hiroshi Hirayama, Yutaka |
AuthorAffiliation | 2 Department of Thoracic Surgery Tazuke Kofukai Medical Research Institute, Kitano Hospital Osaka Japan 3 Department of Respiratory Medicine, Graduate School of Medicine Kyoto University Kyoto Japan 1 Department of Thoracic Surgery, Graduate School of Medicine Kyoto University Kyoto Japan 4 Department of Diagnostic Pathology Kyoto University Hospital Kyoto Japan |
AuthorAffiliation_xml | – name: 3 Department of Respiratory Medicine, Graduate School of Medicine Kyoto University Kyoto Japan – name: 1 Department of Thoracic Surgery, Graduate School of Medicine Kyoto University Kyoto Japan – name: 2 Department of Thoracic Surgery Tazuke Kofukai Medical Research Institute, Kitano Hospital Osaka Japan – name: 4 Department of Diagnostic Pathology Kyoto University Hospital Kyoto Japan |
Author_xml | – sequence: 1 givenname: Ryota orcidid: 0000-0002-1676-1571 surname: Sumitomo fullname: Sumitomo, Ryota organization: Tazuke Kofukai Medical Research Institute, Kitano Hospital – sequence: 2 givenname: Toshi surname: Menju fullname: Menju, Toshi email: toshimnj@kuhp.kyoto‐u.ac.jp organization: Kyoto University – sequence: 3 givenname: Yumeta surname: Shimazu fullname: Shimazu, Yumeta organization: Kyoto University – sequence: 4 givenname: Toshiya surname: Toyazaki fullname: Toyazaki, Toshiya organization: Kyoto University – sequence: 5 givenname: Naohisa surname: Chiba fullname: Chiba, Naohisa organization: Kyoto University – sequence: 6 givenname: Hideaki surname: Miyamoto fullname: Miyamoto, Hideaki organization: Kyoto University – sequence: 7 givenname: Yutaka surname: Hirayama fullname: Hirayama, Yutaka organization: Kyoto University – sequence: 8 givenname: Shigeto surname: Nishikawa fullname: Nishikawa, Shigeto organization: Kyoto University – sequence: 9 givenname: Satona surname: Tanaka fullname: Tanaka, Satona organization: Kyoto University – sequence: 10 givenname: Yojiro surname: Yutaka fullname: Yutaka, Yojiro organization: Kyoto University – sequence: 11 givenname: Yoshito surname: Yamada fullname: Yamada, Yoshito organization: Kyoto University – sequence: 12 givenname: Daisuke surname: Nakajima fullname: Nakajima, Daisuke organization: Kyoto University – sequence: 13 givenname: Akihiro surname: Ohsumi fullname: Ohsumi, Akihiro organization: Kyoto University – sequence: 14 givenname: Masatsugu surname: Hamaji fullname: Hamaji, Masatsugu organization: Kyoto University – sequence: 15 givenname: Atsuyasu surname: Sato fullname: Sato, Atsuyasu organization: Kyoto University – sequence: 16 givenname: Akihiko surname: Yoshizawa fullname: Yoshizawa, Akihiko organization: Kyoto University Hospital – sequence: 17 givenname: Cheng‐Long surname: Huang fullname: Huang, Cheng‐Long organization: Tazuke Kofukai Medical Research Institute, Kitano Hospital – sequence: 18 givenname: Hironori surname: Haga fullname: Haga, Hironori organization: Kyoto University Hospital – sequence: 19 givenname: Hiroshi surname: Date fullname: Date, Hiroshi organization: Kyoto University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37806311$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1u1DAUhQMqoj-w6AsgS2xgMR3np3G8QtWIP6mIRbu3bpybiUtsp7bDMKz6CEi8CQ_CQ_RJcGamCCrIxrF9zsl3o3OY7BlrMEmOU3qSxmcuwZ-kp7xiD5ODNC_4jFFa7m3e2YzTPNtPDr2_ojQvC148TvZzVtEyT9ODB8cfstubb736hCSM2rq4Ae-tVBCwIRqks0MHS_RkcFbbgAQHFTrsFfS3N981ejSyW2voSXBgvArKGhI6Z8dlF1fcHrfWaWWWZOnsKnSkBRmsIz9_zC80NPOvykjSxnt0BCNBbb-QWplmcnRWo50OBgjdCtZkFT9PosEh-AkRA_gAQUkyRDwTIhgB02zHIRL7fkLvVYsONnDKkH6Myf56BG1Hv9VIcFIZq-FJ8qiF3uPT3XqUXL55fbl4Nzv_-Pb94ux8JouyYrMaaZ0i5azOMsY4AAPanFYty9OiLKAomjzlsuKQlWXL26ylVV1mWOdReMrr_Ch5tY0dxlpjIyO5g14MTmlwa2FBib9vjOrE0n4WKWVZRVMaE17sEpy9HtEHoZWfZgGDcSyRVayockZzFqXP70mv7OhMHE9ksR-UF7zkUfXsT6TfLHdtiYL5VhBb4b3DVkgVNj81Eqo-oompjyL2UWz6GB0v7znuQv-l3aWvVI_r_wvF4uxi6_gFtS_9Hw |
CitedBy_id | crossref_primary_10_1002_cam4_70670 crossref_primary_10_1007_s00262_025_03960_1 crossref_primary_10_1016_j_tranon_2025_102324 crossref_primary_10_3389_fphar_2024_1404687 crossref_primary_10_1016_j_imlet_2025_106970 crossref_primary_10_1016_j_intimp_2024_113811 crossref_primary_10_2174_0113892037315736240907131856 crossref_primary_10_3390_ijms25031857 crossref_primary_10_1080_17435390_2024_2314473 crossref_primary_10_1016_j_ejro_2024_100563 |
Cites_doi | 10.1016/S0140-6736(16)30958-8 10.1088/1758-5090/aaafbc 10.1056/NEJMoa1501824 10.1016/j.lungcan.2019.08.023 10.3892/or.2022.8284 10.1038/nm0798-844 10.3389/fonc.2022.911410 10.1038/nrm3758 10.1186/s12935-018-0620-1 10.3390/cancers13164122 10.1016/j.lungcan.2022.11.015 10.1016/j.cell.2016.06.028 10.1186/s12964-020-00557-2 10.1186/s12865-018-0241-4 10.3892/or.2022.8282 10.1186/s13046-018-0981-2 10.1007/s11748-021-01595-4 10.1002/cam4.556 10.18632/oncotarget.9079 10.1186/s13046-020-01808-3 10.1186/s12885-022-10210-5 10.1186/s13046-021-02222-z 10.1073/pnas.1707929115 10.3389/fonc.2023.1110440 10.1126/scitranslmed.aax6337 10.1158/0008-5472.CAN-18-2052 10.1007/978-3-319-40618-3 10.3390/cells9051303 10.3892/ijo.2015.2861 10.1016/j.lungcan.2018.12.001 10.3892/or.2018.6657 10.1200/JCO.2005.02.2871 10.21873/anticanres.14311 10.3390/molecules24010009 10.1038/cr.2009.5 10.1186/s12964-020-00646-2 10.3892/etm.2019.8068 10.1158/1078-0432.CCR-11-2370 10.1002/1878-0261.12606 10.3892/or.2022.8404 10.1038/s41597-023-02074-6 10.2147/CMAR.S200819 |
ContentType | Journal Article |
Copyright | 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. 2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. – notice: 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. – notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1111/cas.15987 |
DatabaseName | Wiley Online Library Open Access CrossRef PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni) PML(ProQuest Medical Library) Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed CrossRef |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Sumitomo et al |
EISSN | 1349-7006 |
EndPage | 4534 |
ExternalDocumentID | PMC10728010 37806311 10_1111_cas_15987 CAS15987 |
Genre | researchArticle Journal Article |
GrantInformation_xml | – fundername: Japan Society for the Promotion of Science funderid: 20H03770 – fundername: Japan Society for the Promotion of Science grantid: 20H03770 |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 24P 29B 2WC 31~ 36B 3O- 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88E 8FE 8FH 8FI 8FJ 8UM 930 A01 A03 AAFWJ AAMMB AAZKR ABCQN ABEML ABUWG ACCMX ACSCC ACXQS ADBBV ADKYN ADPDF ADZMN AEFGJ AENEX AFBPY AFEBI AFFNX AFKRA AFPKN AFZJQ AGXDD AIDQK AIDYY ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BBNVY BCNDV BENPR BFHJK BHPHI BY8 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DR2 DU5 E3Z EBS EJD EMB EMOBN EX3 F00 F01 F04 F5P FIJ FYUFA GODZA GROUPED_DOAJ HCIFZ HF~ HMCUK HOLLA HYE HZI HZ~ IAO IHR ITC IX1 J0M K.9 K48 KQ8 LC2 LC3 LH4 LK8 LP6 LP7 LW6 M1P M7P MK4 N04 N05 N9A O9- OIG OK1 OVD P2P P2X P2Z P4B P4D PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PROAC PSQYO Q11 ROL RPM RX1 SJN SUPJJ SV3 TEORI UB1 UKHRP W8V WIN WOW WQJ WXI X7M XG1 ZXP ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c4687-be0b1e097b22779aa7a0d58f731464a44d319c89a266f9f2f08b62eb3a7a59b3 |
IEDL.DBID | 7X7 |
ISSN | 1347-9032 1349-7006 |
IngestDate | Thu Aug 21 18:37:37 EDT 2025 Mon Jul 21 10:16:28 EDT 2025 Wed Aug 13 11:32:35 EDT 2025 Mon Jul 21 06:06:34 EDT 2025 Tue Jul 01 01:31:17 EDT 2025 Thu Apr 24 22:58:54 EDT 2025 Wed Aug 20 07:27:05 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | tumor-associated macrophage epithelial-mesenchymal transition vimentin E-cadherin lung squamous cell carcinoma |
Language | English |
License | Attribution-NonCommercial 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4687-be0b1e097b22779aa7a0d58f731464a44d319c89a266f9f2f08b62eb3a7a59b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-1676-1571 |
OpenAccessLink | https://www.proquest.com/docview/2903094969?pq-origsite=%requestingapplication% |
PMID | 37806311 |
PQID | 2903094969 |
PQPubID | 4378882 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10728010 proquest_miscellaneous_2874837037 proquest_journals_2903094969 pubmed_primary_37806311 crossref_citationtrail_10_1111_cas_15987 crossref_primary_10_1111_cas_15987 wiley_primary_10_1111_cas_15987_CAS15987 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2023 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: December 2023 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Tokyo – name: Hoboken |
PublicationTitle | Cancer science |
PublicationTitleAlternate | Cancer Sci |
PublicationYear | 2023 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
References | 2015; 35 2021; 69 2023; 10 2023; 13 2015; 4 2020; 40 2019; 11 2019; 79 2022; 47 2016; 166 2019; 18 2020; 14 2022; 48 2012; 18 2022; 41 2018; 40 2020; 12 2019; 128 2022; 22 2005; 23 2018; 24 2020; 18 2015; 372 2015; 46 2018; 19 2021; 13 2018; 18 2016; 7 2023; 175 2018; 115 2020; 9 2022; 12 2014; 15 2019; 136 2017 2015 2009; 19 2018; 10 2017; 389 1998; 4 2021; 40 2018; 37 e_1_2_11_10_1 Attramadal CG (e_1_2_11_29_1) 2015; 35 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_36_1 e_1_2_11_14_1 e_1_2_11_13_1 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 Travis WD (e_1_2_11_25_1) 2015 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 e_1_2_11_21_1 e_1_2_11_44_1 e_1_2_11_20_1 e_1_2_11_45_1 e_1_2_11_40_1 e_1_2_11_24_1 e_1_2_11_41_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_43_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_37_1 e_1_2_11_38_1 e_1_2_11_39_1 e_1_2_11_19_1 |
References_xml | – volume: 19 start-page: 3 year: 2018 article-title: Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non‐small cell lung cancer publication-title: BMC Immunol – volume: 11 start-page: 3419 year: 2019 end-page: 3432 article-title: Statins may have double‐edged effects in patients with lung adenocarcinoma after lung resection publication-title: Cancer Manag Res – volume: 13 year: 2023 article-title: The role of targeted therapy and immune therapy in the management of non‐small cell lung cancer brain metastases publication-title: Front Oncol – volume: 389 start-page: 299 year: 2017 end-page: 311 article-title: Lung cancer: current therapies and new targeted treatments publication-title: Lancet – volume: 18 start-page: 120 year: 2018 article-title: Tumor‐associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck publication-title: Cancer Cell Int – volume: 9 start-page: 1303 year: 2020 article-title: Lung tumor cell‐derived exosomes promote M2 macrophage polarization publication-title: Cell – volume: 175 start-page: 36 year: 2023 end-page: 46 article-title: A novel cell‐based assay for the high‐throughput screening of epithelial‐mesenchymal transition inhibitors: identification of approved and investigational drugs that inhibit epithelial‐mesenchymal transition publication-title: Lung Cancer – volume: 46 start-page: 1844 year: 2015 end-page: 1848 article-title: Critical contribution of MCL‐1 in EMT‐associated chemo‐resistance in A549 non‐small cell lung cancer publication-title: Int J Oncol – volume: 22 start-page: 1208 year: 2022 article-title: Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p‐AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma publication-title: BMC Cancer – volume: 18 start-page: 2443 year: 2012 end-page: 2451 article-title: Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities publication-title: Clin Cancer Res – volume: 41 start-page: 10 year: 2022 article-title: M1‐like tumor‐associated macrophages cascade a mesenchymal/stem‐like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop publication-title: J Exp Clin Cancer Res – volume: 115 start-page: E2801 year: 2018 end-page: E2810 article-title: Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition publication-title: Proc Natl Acad Sci USA – volume: 47 start-page: 73 year: 2022 article-title: Differential expression of PD‐L1 and PD‐L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‐small cell lung cancer publication-title: Oncol Rep – volume: 47 start-page: 71 year: 2022 article-title: Inhibition of the VEGF signaling pathway attenuates tumor‐associated macrophage activity in liver cancer publication-title: Oncol Rep – volume: 35 start-page: 6111 year: 2015 end-page: 6120 article-title: Tumor budding, EMT and cancer stem cells in T1‐2/N0 Oral squamous cell carcinomas publication-title: Anticancer Res – volume: 40 start-page: 13 year: 2021 article-title: Promotion of epithelial‐mesenchymal transformation by hepatocellular carcinoma‐educated macrophages through Wnt2b/β‐catenin/c‐Myc signaling and reprogramming glycolysis publication-title: J Exp Clin Cancer Res – volume: 12 year: 2020 article-title: Mannose receptor (CD206) activation in tumor‐associated macrophages enhances adaptive and innate antitumor immune responses publication-title: Sci Transl Med – volume: 128 start-page: 13 year: 2019 end-page: 19 article-title: Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial‐mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma publication-title: Lung Cancer – volume: 37 start-page: 307 year: 2018 article-title: The epithelial‐to‐mesenchymal transition induced by tumor‐associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer publication-title: J Exp Clin Cancer Res – volume: 372 start-page: 2018 year: 2015 end-page: 2028 article-title: Pembrolizumab for the treatment of non‐small‐cell lung cancer publication-title: N Engl J Med – volume: 166 start-page: 21 year: 2016 end-page: 45 article-title: EMT: 2016 publication-title: Cell – volume: 14 start-page: 462 year: 2020 end-page: 483 article-title: Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β‐catenin signaling publication-title: Mol Oncol – volume: 69 start-page: 781 year: 2021 end-page: 789 article-title: Lung cancer and epithelial‐mesenchymal transition publication-title: Gen Thorac Cardiovasc Surg – volume: 79 start-page: 1658 year: 2019 end-page: 1670 article-title: Epithelial‐to‐mesenchymal transition is a mechanism of ALK inhibitor resistance in lung cancer independent of ALK mutation status publication-title: Cancer Res – volume: 13 start-page: 4122 year: 2021 article-title: Esophageal cancer‐derived extracellular vesicle miR‐21‐5p contributes to EMT of ESCC cells by disorganizing macrophage polarization publication-title: Cancers (Basel) – volume: 24 start-page: 9 year: 2018 article-title: Molecular repolarisation of tumour‐associated macrophages publication-title: Molecules – volume: 12 year: 2022 article-title: Progress of tumor‐associated macrophages in the epithelial‐mesenchymal transition of tumor publication-title: Front Oncol – volume: 7 start-page: 34217 year: 2016 end-page: 34228 article-title: Prognostic impact of tumor‐associated macrophage infiltration in non‐small cell lung cancer: a systemic review and meta‐analysis publication-title: Oncotarget – volume: 40 start-page: 3287 year: 2020 end-page: 3296 article-title: Tranilast inhibits TGF‐β1‐induced epithelial‐mesenchymal transition and invasion/metastasis via the suppression of Smad4 in human lung cancer cell lines publication-title: Anticancer Res – volume: 23 start-page: 8765 year: 2005 end-page: 8773 article-title: Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor–An expression in non‐small‐cell lung cancer publication-title: J Clin Oncol – volume: 4 start-page: 844 year: 1998 end-page: 847 article-title: Tissue microarrays for high‐throughput molecular profiling of tumor specimens publication-title: Nat Med – volume: 18 start-page: 51 year: 2020 article-title: Wnt5a‐induced M2 polarization of tumor‐associated macrophages via IL‐10 promotes colorectal cancer progression publication-title: Cell Commun Signal – volume: 15 start-page: 178 year: 2014 end-page: 196 article-title: Molecular mechanisms of epithelial‐mesenchymal transition publication-title: Nat Rev Mol Cell Biol – volume: 4 start-page: 1853 year: 2015 end-page: 1862 article-title: Association between epithelial‐mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma publication-title: Cancer Med – volume: 19 start-page: 156 year: 2009 end-page: 172 article-title: TGF‐beta‐induced epithelial to mesenchymal transition publication-title: Cell Res – year: 2017 – volume: 10 year: 2018 article-title: Matrix stiffness and tumor‐associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells publication-title: Biofabrication – volume: 18 start-page: 143 year: 2020 article-title: Non‐canonical Fzd7 signaling contributes to breast cancer mesenchymal‐like stemness involving Col6a1 publication-title: Cell Commun Signal – volume: 10 start-page: 167 year: 2023 article-title: An integrated single‐cell transcriptomic dataset for non‐small cell lung cancer publication-title: Sci Data – volume: 136 start-page: 136 year: 2019 end-page: 144 article-title: PD‐L1 expression on tumor‐infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non‐small cell lung cancer publication-title: Lung Cancer – volume: 40 start-page: 2558 year: 2018 end-page: 2572 article-title: Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma publication-title: Oncol Rep – year: 2015 – volume: 18 start-page: 4490 year: 2019 end-page: 4498 article-title: M2 tumor‐associated macrophages promote tumor progression in non‐small‐cell lung cancer publication-title: Exp Ther Med – volume: 48 start-page: 189 year: 2022 article-title: Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non‐small cell lung cancer publication-title: Oncol Rep – ident: e_1_2_11_5_1 doi: 10.1016/S0140-6736(16)30958-8 – ident: e_1_2_11_18_1 doi: 10.1088/1758-5090/aaafbc – ident: e_1_2_11_4_1 doi: 10.1056/NEJMoa1501824 – ident: e_1_2_11_7_1 doi: 10.1016/j.lungcan.2019.08.023 – ident: e_1_2_11_8_1 doi: 10.3892/or.2022.8284 – ident: e_1_2_11_26_1 doi: 10.1038/nm0798-844 – ident: e_1_2_11_12_1 doi: 10.3389/fonc.2022.911410 – ident: e_1_2_11_14_1 doi: 10.1038/nrm3758 – ident: e_1_2_11_21_1 doi: 10.1186/s12935-018-0620-1 – ident: e_1_2_11_20_1 doi: 10.3390/cancers13164122 – ident: e_1_2_11_45_1 doi: 10.1016/j.lungcan.2022.11.015 – ident: e_1_2_11_15_1 doi: 10.1016/j.cell.2016.06.028 – ident: e_1_2_11_34_1 doi: 10.1186/s12964-020-00557-2 – ident: e_1_2_11_10_1 doi: 10.1186/s12865-018-0241-4 – ident: e_1_2_11_30_1 doi: 10.3892/or.2022.8282 – ident: e_1_2_11_38_1 doi: 10.1186/s13046-018-0981-2 – ident: e_1_2_11_36_1 doi: 10.1007/s11748-021-01595-4 – volume-title: WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart year: 2015 ident: e_1_2_11_25_1 – ident: e_1_2_11_27_1 doi: 10.1002/cam4.556 – ident: e_1_2_11_9_1 doi: 10.18632/oncotarget.9079 – ident: e_1_2_11_32_1 doi: 10.1186/s13046-020-01808-3 – ident: e_1_2_11_19_1 doi: 10.1186/s12885-022-10210-5 – ident: e_1_2_11_23_1 doi: 10.1186/s13046-021-02222-z – volume: 35 start-page: 6111 year: 2015 ident: e_1_2_11_29_1 article-title: Tumor budding, EMT and cancer stem cells in T1‐2/N0 Oral squamous cell carcinomas publication-title: Anticancer Res – ident: e_1_2_11_42_1 doi: 10.1073/pnas.1707929115 – ident: e_1_2_11_3_1 doi: 10.3389/fonc.2023.1110440 – ident: e_1_2_11_41_1 doi: 10.1126/scitranslmed.aax6337 – ident: e_1_2_11_40_1 doi: 10.1158/0008-5472.CAN-18-2052 – ident: e_1_2_11_24_1 doi: 10.1007/978-3-319-40618-3 – ident: e_1_2_11_31_1 doi: 10.3390/cells9051303 – ident: e_1_2_11_39_1 doi: 10.3892/ijo.2015.2861 – ident: e_1_2_11_13_1 doi: 10.1016/j.lungcan.2018.12.001 – ident: e_1_2_11_22_1 doi: 10.3892/or.2018.6657 – ident: e_1_2_11_37_1 doi: 10.1200/JCO.2005.02.2871 – ident: e_1_2_11_43_1 doi: 10.21873/anticanres.14311 – ident: e_1_2_11_11_1 doi: 10.3390/molecules24010009 – ident: e_1_2_11_16_1 doi: 10.1038/cr.2009.5 – ident: e_1_2_11_17_1 doi: 10.1186/s12964-020-00646-2 – ident: e_1_2_11_6_1 doi: 10.3892/etm.2019.8068 – ident: e_1_2_11_2_1 doi: 10.1158/1078-0432.CCR-11-2370 – ident: e_1_2_11_33_1 doi: 10.1002/1878-0261.12606 – ident: e_1_2_11_35_1 doi: 10.3892/or.2022.8404 – ident: e_1_2_11_28_1 doi: 10.1038/s41597-023-02074-6 – ident: e_1_2_11_44_1 doi: 10.2147/CMAR.S200819 |
SSID | ssj0036494 |
Score | 2.4940677 |
Snippet | Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor‐associated macrophages (TAMs) in... Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in... Epithelial‑mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4521 |
SubjectTerms | Cancer therapies CD163 antigen Cell proliferation Cells E-cadherin Enzyme-linked immunosorbent assay epithelial–mesenchymal transition Growth factors Homeobox Immunohistochemistry Leukocyte migration Ligands Lung cancer Lung carcinoma lung squamous cell carcinoma Macrophages Medical prognosis Metastases Metastasis Monocytes Nitric oxide Original Patients Smad protein Smad3 protein Squamous cell carcinoma Stroma Transcription factors Transforming growth factor-b Transforming growth factor-b1 Tumors tumor‐associated macrophage Vascular endothelial growth factor Vimentin Western blotting Zinc finger proteins |
SummonAdditionalLinks | – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEDZVD4gLlP-lBRnEgUvaJPYmsThVFVWFtBxokXpAisaJw66an2U3q_6c-ghIvAkPwkP0SZixs1GXgoQ4ZZOMN-N4PDOxZ-Zj7HWhDUgJ4KE4hZ7MhPBA5MqLBQwzkcgCbPrY6EN08Em-Px4er7G3y1wYVx-iX3CjmWH1NU1w0PNrk5wgwdAWJ5RJTrFa5BB97EtHiUgqB2grY0_5IuyqClEUT99y1RbdcDBvxkle91-tAdq_xz4vWXdxJyfbi1ZvZxe_VXX8z75tsLudY8p3nSTdZ2umfsBuj7qt94e3Nkbh1eW3cnJieLuomhmeQDe0JucVEBTYGJXTnE9thJ_hZkr5HiUK-NXl94qynLLxeYXPaMk-2lAx3sEE4dG4y-RDozXlX2bNaTvmDg6I__yxc1hBvnMxqTNe2JVIbpAD3ZxxPbGJOXzcVKahCwSyfArnnJaYOTagsHti0bRA6VOTjE-RvRpVW8mhzl13OO1gEOslxfpYccW2vERdyOdfF0ArJI4mI_SluqngETvaf3e0d-B1eBJeJiPUpdr4OjC-inUYxrECiMHPh0kRCzQXEkU2R32UJQrQaSlUERZ-oqPQaIGEQ6XFY7ZeN7V5yngYAxWqi7NIGkniXgyFAZ0UQU4ftWbA3iwFK826WusE-VGmy28uHOHUjvCAvepJp67AyJ-ItpbSmXY6Zp6GirbHpIrUgL3sb6N2oJcBtcH3khKaAZU3EvgXT5ww908RcYL-aRAMWLIi5j0BVR5fvVNPxrYCeeATqlngYz-tGP-d83Rv99D-ePbvpJvsToiupAsa2mLr7WxhnqPr1-oXdo7_AsQOY_M priority: 102 providerName: Wiley-Blackwell |
Title | M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcas.15987 https://www.ncbi.nlm.nih.gov/pubmed/37806311 https://www.proquest.com/docview/2903094969 https://www.proquest.com/docview/2874837037 https://pubmed.ncbi.nlm.nih.gov/PMC10728010 |
Volume | 114 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbhMxEDa0lRAcEP8ESmQQBy5WNraz3j2hUrWqkFJVbZFyW9leL4nYn7TZCMqJd-BNeBAegidhxuuEVgUuSbQ7u7G9386Mx-P5CHldGKel1JoBnDiTVgimRZ4yJfTIikQW2m8fGx_GBx_k-8loEgJui5BWudKJXlHnjcUY-YCnuBgg0zh9Oz9jyBqFq6uBQmODbGHpMkS1mqwnXCKWaUdqKxWDy3moLISZPEgoBpYcM-ku26NrTub1XMnLPqw3Qvv3yN3gPdKd7nHfJzdd_YDcGof18Yc37ow5K2efHG2XVXPOdBh7l9NKI1fXFLTHgs59Cp6jbo4bMkpA4K9v3yvchmSnFxXcv0UD5nO5aODxgW_XHUYnF8wd_Qjz93ZKO74e-vPH4KTS-eDrrLa08KFC6phpvlAz8_tm6LSpXIMHkAP5s76gGAGmII5Z8dhA12rc3TSzdA6Nq0HzlFTXedcVigsM2PASU3E8muBaWoKqoouzpcYARidjkRypbir9iJzu753uHrBA98CsjEHVGReZoYtSZThXKtVa6SgfJYUSoM0lICoHdWGTVINPUaQFL6LExNwZAYKj1IjHZLNuaveUUK401pFTNpZOIhqLkXDaJMUwxzmn65E3q2ee2VAKHRk5ymw1JQJ4ZB4ePfJqLTrv6n_8TWh7BZwsqIBF9gewPfJyfRpeXhwMXTsYlwzJBrD6kIBbPOlwtv4XoRJwH4fDHkmuIHAtgIXBr56pZ1NfIBym9Bw8jwj66cH675Znuzsn_sez_3fhObnNwbvr8ni2yWZ7vnQvwBtrTZ9scHnU9y9en2y92zs8Ou77yAZ-HvPfLd1C4A |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB1KkXgsEG8CBQYEUjejODMTPxYIVYUqpU03DVJ21ng8xhF-pImjEFb8A9_Bhg_hI_gS7h3boVWBXVeJ7BvnjufMfczcByEvk8goKZViACfOpBaCKREHzBOqr4UvE2XTx4ZH7uCDfD_ujzfI9zYXBsMqW5loBXVcatwj7_IADwNk4AZvpicMu0bh6WrbQqOGxYFZLcFlm7_efwvz-4rzvXej3QFrugowLV1YUZFxop5xAi_i3PMCpTzlxH0_8QQIDQmMx4BK7QcKVFcSJDxx_Mjl4HMCYT-IBDz2MrkCetdBX88br_074cqg7qErPQbc8qaQEQYOYf8yMBwwcO-0-jtn054PzTxtMludt3eL3GyMVbpTo-s22TDFHXJ12BzH3710Y8hZNvlkaLXIyxlTzVSbmOYKW4OlIKzmdGoj_gw1U8z_yADwv75-yzHrSaerHJ5fob60oWO0aRsEn6a-jDY1aFf6cVYuq5TW7YHozx_d41zF3S-TQtPE7kxSw6LyM40mNk2HpmVuSryALZeXakVxw5kCOQbhI4OmUphMNdF0CswVIOgyqoq4HgrF8wxkPMPIHwte-C3NQDLS-clC4X5JTaOxF1NR5uoeGV0EDu6TzaIszENCuaewbJ2nXWkkgj_pC6MiP-nF6OKaDtlu5zzUTeV1bACSha0HBvAILTw65MWadFqXG_kb0VYLnLCROPPwz_rokOfr2yAr8GWowsB7CbG3ARY7EvCIBzXO1v8iPB-s1V6vQ_wzCFwTYB3ys3eKSWrrkcNK4GDoODBOC9Z_cx7u7hzbL4_-P4Rn5NpgNDwMD_ePDh6T6xwMyzqEaItsVrOFeQKGYBU9tcuPkvCCl_tvRdB6AA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF5KKlVwQPwVAgUWBBKXVez1xmsfECpto5aSqKJF6s1a2-smqn_SxFEIJ96BN-HGS_AQPAkzazu0KnDrKZE9cXa9387M7s7MR8jLJNRKCKUYwIkzETkOU07sM-mobuR4IlEmfaw_cHc_iffH3eMV8qPJhcGwykYnGkUdFxHukXe4j4cBwnf9TlKHRRxs996OzxgySOFJa0OnUUFkXy_msHybvtnbhrF-xXlv52hrl9UMAywSLsyuUFuhrS1fhpxL6SsllRV3vUQ6oEAEdCIGhEaer8CMJX7CE8sLXQ7rTxDs-qEDj71OViUuilpk9d3O4OBjYwYcV_gVo66QDNrO67JGGEaEbGbgRmAY33ljeMnDvRyoed6BNhawd5vcql1Xullh7Q5Z0fldstavD-fvXbvZ5ywdnWpazrJiwlQ98DqmmUKisCGorikdm_g_TfUYs0FSgP-vr98yzIGKhosMnl-i9TSBZLQmEYJPXV1GDxtsLT2ZFPNySCuyIPrze-cwU3HnyyiPaGL2KalmYfGZhiOTtEOHRaYLvIAEzHO1oLj9TEEcQ_KxgbpUmFo1iugYGpeD2kupyuOqKxRPN7DhKcYBGSjDb2kKepJOz2YKd08qmQiZmfIiU_fJ0VUgYZ208iLXDwnlUmEROxm5QgucCknX0Sr0EjvGBa9uk9fNmAdRXYcd6UDSoFmPATwCA482ebEUHVfFR_4mtNEAJ6j1zzT4M1va5PnyNmgOfBkq1_BeAmQ6wNJHDjziQYWz5b840gPf1bbbxLuAwKUAViW_eCcfDU11cttCxjPbgn4asP675cHW5qH58uj_XXhG1mCqBx_2BvuPyQ0OXmYVT7RBWuVkpp-AV1iGT-v5R0lwxTP-N8hcf5s |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=M2-like+tumor-associated+macrophages+promote+epithelial%E2%80%93mesenchymal+transition+through+the+transforming+growth+factor+%CE%B2%2FSmad%2Fzinc+finger+e-box+binding+homeobox+pathway+with+increased+metastatic+potential+and+tumor+cell+proliferation+in+lung+squamous+cell+carcinoma&rft.jtitle=Cancer+science&rft.au=Sumitomo%2C+Ryota&rft.au=Menju%2C+Toshi&rft.au=Shimazu%2C+Yumeta&rft.au=Toyazaki%2C+Toshiya&rft.date=2023-12-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1347-9032&rft.eissn=1349-7006&rft.volume=114&rft.issue=12&rft.spage=4521&rft.epage=4534&rft_id=info:doi/10.1111%2Fcas.15987&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-9032&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-9032&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-9032&client=summon |